NA
NEPH icon

Navellier & Associates’s Nephros NEPH Stock Holding History

Navellier & Associates’s Portfolio NEPH Stock Details NEPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$191K Buy
53,479
+34,353
+180% +$112K 0.02% 315
2026
Q1 		$57K Sell
19,126
-8,049
-30% -$32.1K 0.01% 326
2025
Q4 		$133K Buy
+27,175
New +$139K 0.01% 322

Other funds holding NEPH

WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $386M AUM 2.37% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
CC
Cornerstone Capital Palo Alto, California $1.12B AUM 28.84% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $451M AUM 66.6% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MFIM
Mesirow Financial Investment Management Chicago, Illinois $6.37B AUM 23.22% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return

Navellier & Associates's NEPH Position: Q2 2026 in Review

Navellier & Associates increased its Nephros (NEPH) stake by 180% in Q2 2026, buying an estimated $112K and bringing the position to 53,479 shares worth $191K. The position accounts for 0.02% of the portfolio, ranked #315.

Navellier & Associates first reported a position in NEPH in Q4 2025 and has held it in 3 quarters since. 33 funds tracked by Wall St. Rank hold NEPH as of Q2 2026.

  • Navellier & Associates held 53,479 shares of Nephros worth $191K as of Q2 2026.
  • Navellier & Associates bought 34,353 Nephros shares in Q2 2026, an estimated $112K.
  • Nephros made up 0.02% of Navellier & Associates's portfolio in Q2 2026, its #315 holding.
  • Navellier & Associates first reported a position in Nephros in Q4 2025 and has held it in 3 quarters since.
  • 33 funds tracked by Wall St. Rank held Nephros as of Q2 2026.

Based on Navellier & Associates's 13F filing for Q2 2026, filed 4 Aug 2026.